Stock comparison
Revolution Medicines, Inc. is 4.2x more valuable than Kymera Therapeutics, Inc. by market capitalization ($40.63 B vs $9.79 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVMD is larger
Revolution Medicines, Inc. is 4.2x more valuable than Kymera Therapeutics, Inc. by market capitalization ($40.63 B vs $9.79 B).
Market value leader
RVMD
Revolution Medicines, Inc. is 4.2x more valuable than Kymera Therapeutics, Inc. by market capitalization ($40.63 B vs $9.79 B).
Revenue leader
KYMR
KYMR: $39.21M vs RVMD: $0.00.
Profit leader
KYMR
KYMR: $311.35M vs RVMD: -$1.13B.
| Metric | KYMR | RVMD |
|---|---|---|
| Market cap | $9.79 B | $40.63 B |
| US-listed rank | #969 | #384 |
| Revenue (latest FY) | $39.21M | $0.00 |
| Net income (latest FY) | $311.35M | -$1.13B |
| Net margin | 794.0% | - |
| P/E (trailing FY) | 31.4x | - |
| SEC filings | 575 | 777 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Revolution Medicines, Inc. is 4.2x more valuable than Kymera Therapeutics, Inc. by market capitalization ($40.63 B vs $9.79 B).
In their latest fiscal years, Kymera Therapeutics, Inc. reported $39.21M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Kymera Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.